TP53 and cancer: Coupled with the absence of p53 analogs encoded by transforming retroviruses, these findings conspired to bring p53’s oncogenic status into question and indeed to marginalize it as a potential cancer driver in comparison to myc, ras, and a host of other ‘classic’ oncogenes then grabbing the headlines at national and international oncogene meetings.